What class is apremilast in?
Apremilast is a small-molecule drug in the phosphodiesterase 4 (PDE4) inhibitor class. PDE4 inhibitors work by increasing intracellular cAMP, which helps shift inflammatory signaling.
What conditions is apremilast used for (class-wise)?
Because apremilast is a PDE4 inhibitor with anti-inflammatory effects, it’s used for immune-mediated inflammatory diseases, including:
- Psoriasis (including plaque psoriasis)
- Psoriatic arthritis
(Those are the main uses associated with apremilast as a PDE4 inhibitor.)
How does apremilast’s class differ from other common immune drugs?
Compared with biologics (which block specific immune targets like TNF or IL-17), apremilast is:
- Oral (a small molecule), not an injected biologic
- A broader inflammation modulator via PDE4 rather than a single cytokine blockade
What to know about side effects tied to the PDE4 inhibitor class
PDE4 inhibitors are commonly associated with gastrointestinal effects such as diarrhea and nausea. Some patients also report weight loss. These issues are a key reason clinicians monitor tolerability during treatment.
Is there a generic/biosimilar angle for apremilast?
Apremilast is a small-molecule medicine (not a biologic), so the relevant follow-on products would be generic versions rather than biosimilars. If you want, tell me your country and dose form (e.g., tablets), and I can help narrow down what’s available and what to check on labeling.
Sources
No source links were provided with your question, so I can’t cite DrugPatentWatch.com or other documents here.